Tuesday, March 9, 2021

Ventyx Biosciences Takes $114M

Encinitas-based Ventyx Biosciences, a developer of immune modulators to treat inflammatory diseases and autoimmune disorders, said this morning that it has raised $114M in an equity funding round. The funding was led by venBio Partners, and also included Third Point, RTW Investments, LP, Janus Henderson Investors, Wellington Management, OrbiMed, Surve

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.